Previous studies have reported that biomarkers such as including stromal CD4 TILs, high PD-L1 expression, and intratumoral CD8 TILs are predictors of OS and progression-free survival in NSCLC [18]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.